Risk factors for death in 1859 subjects with COVID-19

We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated wit...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia Vol. 34; no. 8; pp. 2173 - 2183
Main Authors: Chen, Lei, Yu, Jianming, He, Wenjuan, Chen, Li, Yuan, Guolin, Dong, Fang, Chen, Wenlan, Cao, Yulin, Yang, Jingyan, Cai, Liling, Wu, Di, Ran, Qijie, Li, Lei, Liu, Qiaomei, Ren, Wenxiang, Gao, Fei, Wang, Hongxiang, Chen, Zhichao, Gale, Robert Peter, Li, Qiubai, Hu, Yu
Format: Journal Article
Language:English
Published: England Nature Publishing Group 01.08.2020
Subjects:
ISSN:0887-6924, 1476-5551, 1476-5551
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated with several admission covariates: (1) older age (HR = 1.04; 95% Confidence Interval [CI], 1.03, 1.06 per year increase; P < 0.001); (2) smoking (HR = 1.84 [1.17, 2.92]; P = 0.009); (3) admission temperature per °C increase (HR = 1.32 [1.07, 1.64]; P = 0.009); (4) Log neutrophil-to-lymphocyte ratio (NLR; HR = 3.30 [2.10, 5.19]; P < 0.001); (5) platelets per 10 E + 9/L decrease (HR = 0.996 [0.994, 0.998]; P = 0.001); (6) activated partial thromboplastin (aPTT) per second increase (HR = 1.04 [1.02, 1.05]; P < 0.001); (7) Log D-dimer per mg/l increase (HR = 3.00 [2.17, 4.16]; P < 0.001); and (8) Log serum creatinine per μmol/L increase (HR = 4.55 [2.72, 7.62]; P < 0.001). In piecewise linear regression analyses Log NLR the interval from ≥0.4 to ≤1.0 was significantly associated with an increased risk of death. Our data identify covariates associated with risk of in hospital death in persons with COVID-19.
AbstractList We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated with several admission covariates: (1) older age (HR = 1.04; 95% Confidence Interval [CI], 1.03, 1.06 per year increase; P < 0.001); (2) smoking (HR = 1.84 [1.17, 2.92]; P = 0.009); (3) admission temperature per °C increase (HR = 1.32 [1.07, 1.64]; P = 0.009); (4) Log10 neutrophil-to-lymphocyte ratio (NLR; HR = 3.30 [2.10, 5.19]; P < 0.001); (5) platelets per 10 E + 9/L decrease (HR = 0.996 [0.994, 0.998]; P = 0.001); (6) activated partial thromboplastin (aPTT) per second increase (HR = 1.04 [1.02, 1.05]; P < 0.001); (7) Log10 D-dimer per mg/l increase (HR = 3.00 [2.17, 4.16]; P < 0.001); and (8) Log10 serum creatinine per μmol/L increase (HR = 4.55 [2.72, 7.62]; P < 0.001). In piecewise linear regression analyses Log10NLR the interval from ≥0.4 to ≤1.0 was significantly associated with an increased risk of death. Our data identify covariates associated with risk of in hospital death in persons with COVID-19.We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated with several admission covariates: (1) older age (HR = 1.04; 95% Confidence Interval [CI], 1.03, 1.06 per year increase; P < 0.001); (2) smoking (HR = 1.84 [1.17, 2.92]; P = 0.009); (3) admission temperature per °C increase (HR = 1.32 [1.07, 1.64]; P = 0.009); (4) Log10 neutrophil-to-lymphocyte ratio (NLR; HR = 3.30 [2.10, 5.19]; P < 0.001); (5) platelets per 10 E + 9/L decrease (HR = 0.996 [0.994, 0.998]; P = 0.001); (6) activated partial thromboplastin (aPTT) per second increase (HR = 1.04 [1.02, 1.05]; P < 0.001); (7) Log10 D-dimer per mg/l increase (HR = 3.00 [2.17, 4.16]; P < 0.001); and (8) Log10 serum creatinine per μmol/L increase (HR = 4.55 [2.72, 7.62]; P < 0.001). In piecewise linear regression analyses Log10NLR the interval from ≥0.4 to ≤1.0 was significantly associated with an increased risk of death. Our data identify covariates associated with risk of in hospital death in persons with COVID-19.
We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated with several admission covariates: (1) older age (HR = 1.04; 95% Confidence Interval [CI], 1.03, 1.06 per year increase; P < 0.001); (2) smoking (HR = 1.84 [1.17, 2.92]; P = 0.009); (3) admission temperature per °C increase (HR = 1.32 [1.07, 1.64]; P = 0.009); (4) Log10 neutrophil-to-lymphocyte ratio (NLR; HR = 3.30 [2.10, 5.19]; P < 0.001); (5) platelets per 10 E + 9/L decrease (HR = 0.996 [0.994, 0.998]; P = 0.001); (6) activated partial thromboplastin (aPTT) per second increase (HR = 1.04 [1.02, 1.05]; P < 0.001); (7) Log10 D-dimer per mg/l increase (HR = 3.00 [2.17, 4.16]; P < 0.001); and (8) Log10 serum creatinine per μmol/L increase (HR = 4.55 [2.72, 7.62]; P < 0.001). In piecewise linear regression analyses Log10NLR the interval from ≥0.4 to ≤1.0 was significantly associated with an increased risk of death. Our data identify covariates associated with risk of in hospital death in persons with COVID-19.
We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for correlations with risk of death from COVID-19. In multi-variable Cox regression analyses increased hazards of in-hospital death were associated with several admission covariates: (1) older age (HR = 1.04; 95% Confidence Interval [CI], 1.03, 1.06 per year increase; P < 0.001); (2) smoking (HR = 1.84 [1.17, 2.92]; P = 0.009); (3) admission temperature per °C increase (HR = 1.32 [1.07, 1.64]; P = 0.009); (4) Log neutrophil-to-lymphocyte ratio (NLR; HR = 3.30 [2.10, 5.19]; P < 0.001); (5) platelets per 10 E + 9/L decrease (HR = 0.996 [0.994, 0.998]; P = 0.001); (6) activated partial thromboplastin (aPTT) per second increase (HR = 1.04 [1.02, 1.05]; P < 0.001); (7) Log D-dimer per mg/l increase (HR = 3.00 [2.17, 4.16]; P < 0.001); and (8) Log serum creatinine per μmol/L increase (HR = 4.55 [2.72, 7.62]; P < 0.001). In piecewise linear regression analyses Log NLR the interval from ≥0.4 to ≤1.0 was significantly associated with an increased risk of death. Our data identify covariates associated with risk of in hospital death in persons with COVID-19.
Author Chen, Wenlan
Cao, Yulin
Ren, Wenxiang
Yuan, Guolin
Dong, Fang
Chen, Lei
Chen, Zhichao
He, Wenjuan
Liu, Qiaomei
Chen, Li
Wu, Di
Wang, Hongxiang
Li, Qiubai
Gale, Robert Peter
Ran, Qijie
Yu, Jianming
Gao, Fei
Yang, Jingyan
Cai, Liling
Li, Lei
Hu, Yu
Author_xml – sequence: 1
  givenname: Lei
  surname: Chen
  fullname: Chen, Lei
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 2
  givenname: Jianming
  surname: Yu
  fullname: Yu, Jianming
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 3
  givenname: Wenjuan
  surname: He
  fullname: He, Wenjuan
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 4
  givenname: Li
  surname: Chen
  fullname: Chen, Li
  organization: Department of Hematology, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
– sequence: 5
  givenname: Guolin
  surname: Yuan
  fullname: Yuan, Guolin
  organization: Department of Hematology, Xiangyang Central Hospital, the Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, 441021, China
– sequence: 6
  givenname: Fang
  surname: Dong
  fullname: Dong, Fang
  organization: Intensive Care Units of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China
– sequence: 7
  givenname: Wenlan
  surname: Chen
  fullname: Chen, Wenlan
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 8
  givenname: Yulin
  surname: Cao
  fullname: Cao, Yulin
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 9
  givenname: Jingyan
  surname: Yang
  fullname: Yang, Jingyan
  organization: Department of Urology Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 10
  givenname: Liling
  surname: Cai
  fullname: Cai, Liling
  organization: Department of Urology Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 11
  givenname: Di
  surname: Wu
  fullname: Wu, Di
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 12
  givenname: Qijie
  surname: Ran
  fullname: Ran, Qijie
  organization: Department of Hematology, General Hospital of Central Theater Command, PLA, Wuhan, 300700, China
– sequence: 13
  givenname: Lei
  surname: Li
  fullname: Li, Lei
  organization: Wuhan Jin-Yin-Tan Hospital, Wuhan, China
– sequence: 14
  givenname: Qiaomei
  surname: Liu
  fullname: Liu, Qiaomei
  organization: Medical Records Statistics Department of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China
– sequence: 15
  givenname: Wenxiang
  surname: Ren
  fullname: Ren, Wenxiang
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 16
  givenname: Fei
  surname: Gao
  fullname: Gao, Fei
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 17
  givenname: Hongxiang
  surname: Wang
  fullname: Wang, Hongxiang
  organization: Department of Hematology, Wuhan Central Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
– sequence: 18
  givenname: Zhichao
  surname: Chen
  fullname: Chen, Zhichao
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China
– sequence: 19
  givenname: Robert Peter
  surname: Gale
  fullname: Gale, Robert Peter
  organization: Center for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK
– sequence: 20
  givenname: Qiubai
  orcidid: 0000-0001-7884-0745
  surname: Li
  fullname: Li, Qiubai
  email: qiubaili@hust.edu.cn
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. qiubaili@hust.edu.cn
– sequence: 21
  givenname: Yu
  orcidid: 0000-0002-2815-4568
  surname: Hu
  fullname: Hu, Yu
  email: dr_huyu@126.com
  organization: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. dr_huyu@126.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32546725$$D View this record in MEDLINE/PubMed
BookMark eNqF0EtLxDAQB_AgK-5DP4AXKXjxEs0kmTyOsr4WFhZEvZa0TbDrbrs2LeK3N-J68eJpmP_8GIaZklHTNp6QU2CXwIS5ihKERso4o8wCUHZAJiC1oogIIzJhxmiqLJdjMo1xzdj3UB2RseAoleY4IfhYx7csuLJvu5iFtssq7_rXrG4yMGizOBRrX_Yx-6hTOl-9LG4o2GNyGNwm-pN9nZHnu9un-QNdru4X8-slLdGqnpogpVeoHFZeGzSpLyvrleChMq5AKEBZr60JQTlufQp4Ac4JxyuhTCFm5OJn765r3wcf-3xbx9JvNq7x7RBzLkFKAM1koud_6LoduiZdl5SW1mj4T3GNwkgOSZ3t1VBsfZXvunrrus_8923iC4m_bDA
CitedBy_id crossref_primary_10_1016_j_cmi_2021_11_008
crossref_primary_10_1016_j_mgene_2021_100930
crossref_primary_10_1038_s41375_020_0897_7
crossref_primary_10_1007_s41666_021_00093_9
crossref_primary_10_1097_SHK_0000000000001738
crossref_primary_10_1016_j_jinf_2022_01_040
crossref_primary_10_1186_s13027_021_00400_4
crossref_primary_10_1109_TNSE_2021_3077280
crossref_primary_10_1080_1547691X_2021_1875085
crossref_primary_10_1111_add_15276
crossref_primary_10_1371_journal_pone_0261376
crossref_primary_10_2196_23128
crossref_primary_10_3389_fimmu_2023_1205687
crossref_primary_10_1080_17476348_2020_1804365
crossref_primary_10_3389_fimmu_2020_583019
crossref_primary_10_1186_s12985_020_01396_w
crossref_primary_10_1016_j_beha_2024_101536
crossref_primary_10_1182_blood_2020008150
crossref_primary_10_1590_1806_9282_20210679
crossref_primary_10_1007_s10900_020_00920_x
crossref_primary_10_1016_j_ajem_2021_01_006
crossref_primary_10_1080_1744666X_2022_2120472
crossref_primary_10_1371_journal_pone_0247461
crossref_primary_10_1002_cam4_5426
crossref_primary_10_1155_2022_5474397
crossref_primary_10_1016_j_hlc_2021_02_010
crossref_primary_10_1016_j_ejphar_2023_175501
crossref_primary_10_1038_s41375_020_0986_7
crossref_primary_10_1016_j_blre_2021_100914
crossref_primary_10_3390_jcm13020605
crossref_primary_10_1038_s41375_020_01018_y
crossref_primary_10_1111_ijcp_14596
crossref_primary_10_1080_00365513_2023_2210291
crossref_primary_10_3390_diagnostics12061396
crossref_primary_10_1016_j_eujim_2021_101313
crossref_primary_10_1007_s11356_021_13834_5
crossref_primary_10_1016_j_kint_2020_07_030
crossref_primary_10_1093_ntr_ntac085
crossref_primary_10_4081_mrm_2021_744
crossref_primary_10_1016_j_jiph_2022_05_003
crossref_primary_10_1136_bmjopen_2021_052777
crossref_primary_10_3390_diagnostics12010122
crossref_primary_10_1016_j_clim_2024_110323
crossref_primary_10_1038_s41419_020_03125_1
crossref_primary_10_1016_j_matpr_2022_07_388
crossref_primary_10_1016_j_nmni_2020_100797
crossref_primary_10_2147_IDR_S450504
crossref_primary_10_3390_diagnostics12040859
crossref_primary_10_1021_prechem_3c00056
crossref_primary_10_3390_vaccines10081233
crossref_primary_10_1080_17434440_2021_1915764
crossref_primary_10_1007_s00430_020_00696_w
crossref_primary_10_1038_s41375_021_01374_3
crossref_primary_10_4103_jpbs_jpbs_460_21
crossref_primary_10_1111_jth_15575
crossref_primary_10_1017_dmp_2021_85
crossref_primary_10_1186_s12879_021_06536_3
crossref_primary_10_2174_0250688202666210715141439
crossref_primary_10_1371_journal_pone_0261679
crossref_primary_10_1108_IJSSP_01_2021_0007
crossref_primary_10_1371_journal_pone_0241265
crossref_primary_10_1186_s12889_021_11232_7
crossref_primary_10_3389_fcvm_2021_690790
crossref_primary_10_1177_08850666211045626
crossref_primary_10_3390_vaccines10020326
crossref_primary_10_1080_00031305_2021_1965657
crossref_primary_10_1038_s41598_021_01462_5
crossref_primary_10_1177_0145561320972608
crossref_primary_10_18332_tid_132411
crossref_primary_10_3390_jcm11102780
crossref_primary_10_3390_diagnostics12092089
crossref_primary_10_1038_s41598_024_68946_y
crossref_primary_10_3390_ijerph19148709
crossref_primary_10_3389_fimmu_2021_680134
crossref_primary_10_1177_26335565251371256
crossref_primary_10_5812_archcid_143783
crossref_primary_10_1038_s41467_021_24467_0
crossref_primary_10_1016_j_rmed_2020_106233
crossref_primary_10_1097_MNH_0000000000000692
crossref_primary_10_3389_fphys_2021_624052
crossref_primary_10_1186_s12959_021_00284_9
crossref_primary_10_3390_molecules25235725
crossref_primary_10_1093_rheumatology_keac283
crossref_primary_10_3390_healthcare10122427
crossref_primary_10_33086_ijmlst_v6i1_5405
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer Nature Limited 2020.
Copyright_xml – notice: The Author(s), under exclusive licence to Springer Nature Limited 2020.
DBID CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QL
7RV
7T5
7T7
7TM
7TO
7U9
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7N
M7P
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1038/s41375-020-0911-0
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
ProQuest Nursing and Allied Health Journals - PSU access expires 11/30/25.
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Biological Sciences
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
AIDS and Cancer Research Abstracts
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
ProQuest Medical Library
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Central Student
ProQuest Central Student
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1476-5551
EndPage 2183
ExternalDocumentID 32546725
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 81974221
– fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 81974009
GroupedDBID ---
-Q-
.55
.XZ
0R~
29L
2WC
36B
39C
3V.
4.4
406
53G
5GY
5RE
70F
7RV
7X7
88E
8AO
8C1
8FI
8FJ
8R4
8R5
AACDK
AANZL
AAQQT
AASDW
AASML
AATNV
AAWTL
AAYZH
AAZLF
ABAKF
ABAWZ
ABDBF
ABJNI
ABLJU
ABOCM
ABUWG
ABZZP
ACAOD
ACGFO
ACGFS
ACKTT
ACMJI
ACPRK
ACRQY
ACUHS
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFFNX
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
CGR
COF
CS3
CUY
CVF
DIK
DNIVK
DPUIP
DU5
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EBX
ECM
EE.
EIF
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
EX3
F5P
FDQFY
FEDTE
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IH2
IHR
IHW
INH
INR
ITC
IWAJR
JSO
JZLTJ
KQ8
LGEZI
LOTEE
M1P
M7P
N9A
NADUK
NAO
NAPCQ
NPM
NQJWS
NXXTH
O9-
OK1
OVD
P2P
P6G
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
TUS
UDS
UKHRP
WOW
X7M
Y6R
ZGI
ZXP
~8M
7QL
7T5
7T7
7TM
7TO
7U9
7XB
8FD
8FE
8FH
8FK
ABBRH
ABDBE
ABFSG
ABRTQ
ACSTC
AEZWR
AFDZB
AFHIU
AHWEU
AIXLP
ATHPR
AYFIA
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
LK8
M7N
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c596t-8f44e656a5de78588f4cd9e632fd8ab51b169e798ff6a29e51b2b1aa3a2d368b3
IEDL.DBID 7RV
ISICitedReferencesCount 100
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000543579900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0887-6924
1476-5551
IngestDate Sun Nov 09 11:06:56 EST 2025
Mon Oct 06 17:22:42 EDT 2025
Mon Oct 06 17:14:07 EDT 2025
Wed Feb 19 02:08:30 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c596t-8f44e656a5de78588f4cd9e632fd8ab51b169e798ff6a29e51b2b1aa3a2d368b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-2815-4568
0000-0001-7884-0745
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC7296516
PMID 32546725
PQID 2427538421
PQPubID 30521
PageCount 11
ParticipantIDs proquest_miscellaneous_2414411704
proquest_journals_2474987104
proquest_journals_2427538421
pubmed_primary_32546725
PublicationCentury 2000
PublicationDate 2020-08-01
PublicationDateYYYYMMDD 2020-08-01
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Leukemia
PublicationTitleAlternate Leukemia
PublicationYear 2020
Publisher Nature Publishing Group
Publisher_xml – name: Nature Publishing Group
SSID ssj0014766
Score 2.6202688
Snippet We studied 1859 subjects with confirmed COVID-19 from seven centers in Wuhan 1651 of whom recovered and 208 died. We interrogated diverse covariates for...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 2173
SubjectTerms Adult
Aged
Aged, 80 and over
Betacoronavirus - isolation & purification
Biomarkers - blood
Confidence intervals
Coronavirus Infections - blood
Coronavirus Infections - mortality
Coronavirus Infections - pathology
Coronaviruses
COVID-19
Creatinine
Death
Dimers
Female
Follow-Up Studies
Humans
Lymphocytes
Lymphocytes - pathology
Male
Middle Aged
Mortality
Mortality - trends
Neutrophils - pathology
Pandemics
Platelets
Pneumonia, Viral - blood
Pneumonia, Viral - mortality
Pneumonia, Viral - pathology
Prognosis
Regression analysis
Risk analysis
Risk Factors
ROC Curve
SARS-CoV-2
Severity of Illness Index
Statistical analysis
Survival Rate
Thromboplastin
Title Risk factors for death in 1859 subjects with COVID-19
URI https://www.ncbi.nlm.nih.gov/pubmed/32546725
https://www.proquest.com/docview/2427538421
https://www.proquest.com/docview/2474987104
https://www.proquest.com/docview/2414411704
Volume 34
WOSCitedRecordID wos000543579900001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA6-EC--31oieA022TxPorVFQWspKr2V7G4CRdiq2_r7ndlu9aQXLwO7CeySTDLfzDfJEHJufaLy2IwsAhhgMnDOAIYExnmIKtWZ4El1UPjedLt2MHC9OuBW1mmV8z2x2qjzcYYx8gswJYCsrRT88u2dYdUoZFfrEhqLZJmj7QZ9Nv2XbxZBmhlXiQtJg6MxZzUTe1HC5m3wbHKTgcUEj_p3hFlZms7Gf_9xk6zXGJNezZRiiyyEYpusPtQs-g5R_VH5SutKOxRQK80RCNJRQcGuOlpOU4zOlBSDtLT1-HJ3w7jbJc-d9lPrltXlE1imnJ4wG6UMANe8yoOxysJzlrugExFz61PFU65dMM7GqL1wAV6IlHufeJEn2qbJHlkqxkU4IJQH4Y3S0qXcSRd9Gk1QGdb4Fdp5YQ_JyXxAhvUaKIc_o_FLs5EO3LWmPCRn382g3MhY-CKMp9gH_T1usM_-bE6Gb7NbOIYJ3uRvhDr6-9vHZE1Us4w5eydkafIxDadkJfucjMqPRqUvKAemkhakbfEGWb5ud3v9BqaC9kB2ew9fdX3KXw
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgigX3i2FAkaCo9W14-cBIdRSddXtglBBewtOYkurStnS7FL1T_EbmcmjnMqtB46JrSSyZzzfvPIBvHUh01UaJZ4QDHAVheAIQyIXIiZdmFKKrG0Untjp1M1m_ssa_B56YaiscjgT24O6WpQUI99FU4LI2ikpPpz95MQaRdnVgUKjE4ujeHmBLlvzfryP-_tOyoNPJ3uHvGcV4KX2ZsldUioiigm6itZph9dl5aPJZKpcKLQohPHRepeSCdJHvCELEUIWZJUZV2T43FtwG89xSyVkdnbl4Allu9woKa5Bx2bIomZut0FjYakXesTRQqMHfz2ibS3bwYP_bU0ewv0eQ7OPndA_grVYP4a7x32VwBPQX-fNKeuZhBiiclYR0GXzmiFu8KxZFRR9ahgFodne5-_jfS78U_h2Ix-9Cev1oo7PgIkog9VG-UJ45VMoko26JA5jaXyQbht2hg3Iex1v8r-rf82wVR7d0ZHahjdXw6i8lJEJdVysaA75s8LSnK1OBvKz7i8jeUZMBVbq5_9-92vYODw5nuST8fToBdyTrYRRfeIOrC_PV_El3Cl_LefN-atWVhn8uGlB-AM6JCI9
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB5RqBAXoA8eBVpXao_Wrh0_Dwi1LKuuoNsVaituwUlsaYWUXcguqH-NX8d4k9ATvXHoMbGVRJ4ZzzcP5wP4ZFwii9ANNCAYoMIzRhGGeMqYDzJTOWfJ4qDwmR4OzcWFHS3BfXsWJrZVtnviYqMuJnnMkXfQlSCyNoKzTmjaIka9_tH0mkYGqVhpbek0ahU59X_uMHyrDgc9lPVnzvsnP4-_0YZhgObSqhk1QQiPiMbJwmsjDV7nhfUq4aEwLpMsY8p6bU0IynHr8QbPmHOJ40WiTJbgc1_AikaQgda18vVkODp_rGEIXVdKoxkrDHPammpiOhW6Dh1PRncp-muM55_Gtws_19_4n1doE9YbdE2-1ObwCpZ8-RpWvzf9A29Ano-rK9JwDBHE66SIEJiMS4KIwpJqnsW8VEViepoc__g96FFm38KvZ_noLVguJ6XfAcI8d1oqYTNmhQ0uC9rLPLIbc2UdN7uw3wojbay_Sv9K4olhLSwGql2xCx8fh9GsY63GlX4yj3NipMt0nLNd60M6rf8_kiaRw0Bz-e7f7_4Aqyj_9GwwPN2DNb5Qtti4uA_Ls5u5P4CX-e1sXN28bxSXwOVza8IDwZssXg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Risk+factors+for+death+in+1859+subjects+with+COVID-19&rft.jtitle=Leukemia&rft.au=Chen%2C+Lei&rft.au=Yu%2C+Jianming&rft.au=He%2C+Wenjuan&rft.au=Chen%2C+Li&rft.date=2020-08-01&rft.pub=Nature+Publishing+Group&rft.issn=0887-6924&rft.eissn=1476-5551&rft.volume=34&rft.issue=8&rft.spage=2173&rft.epage=2183&rft_id=info:doi/10.1038%2Fs41375-020-0911-0&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0887-6924&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0887-6924&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0887-6924&client=summon